Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 4:00 pm Purchase | 2022-12-31 | 13G | Rhythm Pharmaceuticals, Inc. RYTM | BAKER BROS. ADVISORS LP | 6,354,608 11.300% | 291,906 (+4.81%) | Filing History |
| 2023-02-14 4:00 pm Purchase | 2022-12-31 | 13G | Inozyme Pharma, Inc. INZY | BAKER BROS. ADVISORS LP | 2,168,000 5.100% | 2,168,000 (New Position) | Filing History |
| 2023-02-14 4:00 pm Purchase | 2022-12-31 | 13G | Kymera Therapeutics, Inc. KYMR | BAKER BROS. ADVISORS LP | 2,879,825 5.200% | 2,879,825 (New Position) | Filing History |
| 2023-02-14 4:00 pm Purchase | 2022-12-31 | 13G | Nurix Therapeutics, Inc. NRIX | BAKER BROS. ADVISORS LP | 4,801,954 9.990% | 2,347,872 (+95.67%) | Filing History |
| 2023-02-14 4:00 pm Purchase | 2022-12-31 | 13G | Madrigal Pharmaceuticals, Inc. MDGL | BAKER BROS. ADVISORS LP | 1,545,113 9.000% | 45,900 (+3.06%) | Filing History |
| 2023-02-10 4:29 pm Sale | 2023-01-31 | 13G | Otonomy, Inc. OTIC | BAKER BROS. ADVISORS LP | 0 0.000% | -3,448,263 (Position Closed) | Filing History |
| 2023-01-17 4:32 pm Purchase | 2023-01-12 | 13D | ACADIA Pharmaceuticals Inc. ACAD | BAKER BROS. ADVISORS LP | 42,306,789 26.100% | 1,138,932 (+2.77%) | Filing History |
| 2022-12-12 4:49 pm Sale | 2022-11-30 | 13G | Amarin Corporation plc AMRN | BAKER BROS. ADVISORS LP | 0 0.000% | -21,293,177 (Position Closed) | Filing History |
| 2022-11-10 4:35 pm Sale | 2022-10-31 | 13G | Otonomy, Inc. OTIC | BAKER BROS. ADVISORS LP | 3,448,263 6.100% | -4,396,429 (-56.04%) | Filing History |
| 2022-10-07 4:20 pm Purchase | 2022-09-30 | 13G | Rhythm Pharmaceuticals, Inc. RYTM | BAKER BROS. ADVISORS LP | 6,062,702 10.900% | 2,199,463 (+56.93%) | Filing History |
| 2022-07-20 5:12 pm Purchase | 2022-07-15 | 13D | Immunocore Holdings plc IMCR | BAKER BROS. ADVISORS LP | 4,685,690 9.930% | 1,333,333 (+39.77%) | Filing History |
| 2022-06-13 5:27 pm Purchase | 2022-06-07 | 13D | Talis Biomedical Corporation TLIS | BAKER BROS. ADVISORS LP | 2,500,336 66.400% | 4,389 (+0.18%) | Filing History |
| 2022-06-13 5:23 pm Purchase | 2022-06-08 | 13D | DBV Technologies S.A. DBVT | BAKER BROS. ADVISORS LP | 1,174,483 24.980% | 616,250 (+110.39%) | Filing History |
| 2022-06-06 5:10 pm Purchase | 2022-06-03 | 13D | Kodiak Sciences Inc. KOD | BAKER BROS. ADVISORS LP | 17,353,846 33.400% | 922,755 (+5.62%) | Filing History |
| 2022-05-18 5:23 pm Purchase | 2022-05-16 | 13D | Kodiak Sciences Inc. KOD | BAKER BROS. ADVISORS LP | 16,431,091 31.600% | 865,023 (+5.56%) | Filing History |
| 2022-05-12 4:45 pm Purchase | 2022-05-10 | 13D | TScan Therapeutics, Inc. TCRX | BAKER BROS. ADVISORS LP | 2,784,792 14.700% | 1,359,792 (+95.42%) | Filing History |
| 2022-04-05 5:15 pm Purchase | 2022-03-29 | 13D | IGM Biosciences, Inc. IGMS | BAKER BROS. ADVISORS LP | 3,169,894 11.600% | 12,110 (+0.38%) | Filing History |
| 2022-03-10 5:20 pm Purchase | 2022-03-08 | 13D | Incyte Corporation INCY | BAKER BROS. ADVISORS LP | 36,634,354 16.500% | 1,417,736 (+4.03%) | Filing History |
| 2022-03-10 4:40 pm Sale | 2022-03-08 | 13D | Seagen Inc. SGEN | BAKER BROS. ADVISORS LP | 47,223,608 25.700% | -394,895 (-0.83%) | Filing History |
| 2022-02-14 4:20 pm Purchase | 2022-02-10 | 13D | Incyte Corporation INCY | BAKER BROS. ADVISORS LP | 35,216,618 15.900% | 2,692,198 (+8.28%) | Filing History |